ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids
L A Pinto, J Sullivan, J A Berzofsky, M Clerici, H A Kessler, A L Landay, G M Shearer, L A Pinto, J Sullivan, J A Berzofsky, M Clerici, H A Kessler, A L Landay, G M Shearer
Abstract
Identification of the components of protective immunity are crucial for the development of effective prophylactic and therapeutic vaccine strategies. Analysis of HIV-specific responses in exposed but uninfected individuals might thus provide a unique resource to elucidate the components and correlates of protective immunity to HIV. In the present study we analyzed HIV-specific cytotoxic and helper T lymphocyte responses in health care workers (HCW) exposed to body fluids from HIV-positive individuals. HCW exposed to blood from HIV-negative individuals as well as healthy donors served as controls. Cytotoxic T lymphocyte (CTL) responses to HIV envelope (env) peptides were detected in 7/20 (35%) HCW exposed to HIV-positive blood and in none of the 20 health care workers exposed to uninfected blood or the seven healthy blood donors studied. HIV-specific CTL responses were detected only after in vitro stimulation, and were MHC class I restricted. No MHC class I restriction elements were uniformly identified among the different responders. 21/28 (75%) HCW exposed to contaminated blood responded to env as measured by IL-2 production to the peptides, in contrast to only 9/38 (24%) HCW exposed to HIV seronegative blood and 3/35 (9%) healthy blood donors. All the HIV exposed individuals were seronegative on repeated ELISA tests, and no evidence of infection was obtained by PCR analysis. These findings indicate that a single exposure to HIV can induce CTL immunity to HIV antigens, in the absence of other evidence of infection.
References
- Nature. 1987 Jul 23-29;328(6128):345-8
- AIDS Res Hum Retroviruses. 1992 Aug;8(8):1355-9
- Science. 1988 Apr 1;240(4848):64-6
- J Virol. 1993 Feb;67(2):694-702
- J Exp Med. 1993 Feb 1;177(2):249-56
- J Virol. 1993 Apr;67(4):1772-7
- Lancet. 1993 Apr 3;341(8849):860-1
- J Immunol. 1993 Apr 15;150(8 Pt 1):3569-81
- J Exp Med. 1993 Jul 1;178(1):27-47
- J Acquir Immune Defic Syndr. 1993 Sep;6(9):969-76
- Eur J Immunol. 1993 Aug;23(8):2022-5
- Semin Immunol. 1993 Jun;5(3):215-23
- Int Immunol. 1993 Aug;5(8):849-57
- Science. 1993 Nov 12;262(5136):1059-61
- JAMA. 1994 Jan 5;271(1):42-6
- J Exp Med. 1994 Jan 1;179(1):317-21
- AIDS. 1993 Nov;7(11):1401-10
- AIDS. 1993 Nov;7(11):1427-33
- J Exp Med. 1994 Feb 1;179(2):463-72
- J Clin Invest. 1994 Mar;93(3):1293-7
- J Infect Dis. 1994 Jun;169(6):1236-43
- J Exp Med. 1994 Jun 1;179(6):1933-43
- J Virol. 1994 Jul;68(7):4650-5
- Adv Immunol. 1979;27:51-177
- J Exp Med. 1986 Apr 1;163(4):903-21
- Nature. 1986 Aug 21-27;322(6081):687-9
- AIDS Res. 1986 Summer;2(3):163-74
- Curr Top Microbiol Immunol. 1986;128:1-54
- Clin Immunol Immunopathol. 1986 Dec;41(3):305-13
- Proc Natl Acad Sci U S A. 1987 Jun;84(12):4249-53
- Nature. 1994 Jun 23;369(6482):648-52
- J Immunol. 1994 Aug 1;153(3):996-1003
- AIDS Res Hum Retroviruses. 1994 Apr;10(4):395-403
- Curr Biol. 1994 Jun 1;4(6):499-505
- Clin Lab Med. 1994 Jun;14(2):271-99
- Curr Opin Immunol. 1994 Aug;6(4):530-8
- Curr Opin Immunol. 1994 Aug;6(4):545-52
- Curr Opin Immunol. 1994 Aug;6(4):553-9
- J Infect Dis. 1994 Nov;170(5):1296-9
- AIDS. 1994 Aug;8(8):1123-8
- AIDS. 1994 Oct;8(10):1391-5
- Proc Natl Acad Sci U S A. 1988 May;85(9):3105-9
- Nature. 1988 May 19;333(6170):215
- Cell. 1988 Sep 9;54(6):777-85
- J Immunol. 1989 Jan 1;142(1):270-3
- J Immunol. 1989 Jan 15;142(2):452-62
- J Exp Med. 1989 Apr 1;169(4):1255-64
- Blood. 1989 May 15;73(7):1909-14
- Nature. 1989 Jun 1;339(6223):383-5
- Nature. 1989 Nov 30;342(6249):561-4
- J Clin Invest. 1989 Dec;84(6):1892-9
- Cell. 1990 Apr 6;61(1):171-83
- AIDS Res Hum Retroviruses. 1990 May;6(5):673-8
- Ann Intern Med. 1990 Nov 15;113(10):740-6
- J Immunol. 1991 Mar 15;146(6):1862-7
- J Immunol. 1991 Apr 1;146(7):2214-9
- Int Immunol. 1989;1(4):409-15
- J Infect Dis. 1991 Jul;164(1):178-82
- Nature. 1991 Sep 12;353(6340):180-4
- J Infect Dis. 1992 Jun;165(6):1012-9
- Mol Aspects Med. 1991;12(4):283-96
- Eur J Immunol. 1992 Sep;22(9):2211-7
- J Med Primatol. 1992 Feb-May;21(2-3):99-107
- J Exp Med. 1988 Mar 1;167(3):914-23
Source: PubMed